Denovicon Therapeutics

San Diego, California, United States

Drug Discovery AI / ML AI drug discovery Therapeutics

Revolutionizing drug discovery with its best-in-class computational drug discovery platform, which integrates AI, machine learning, generative design, and physics-based approaches (e.g., quantum chemistry, statistical mechanics, molecular dynamics, free energy methods) to accelerate the design of next-generation small molecule drugs over multiple therapeutic areas. While Denovicon’s platform is applicable to all therapeutic areas, our in-house projects focus on small-molecule therapeutics within oncology and immunology (especially against various targets in the DNA damage response (DDR) pathways and immuno-oncology).

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Denovicon Therapeutics on @MedStartr Today #Immunology #CancerOncology #DrugDiscovery #AIML #AIDrugDiscovery #Therapeutics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/fm-fH5_Gu_o

Get Involved in Denovicon Therapeutics

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: www.denovicontx.com/

Disease Areas

Immunology Cancer & Oncology

Technologies

Computational Drug DiscoveryAI/Machine LearningSmall Molecule Drugs

🌐Website

What do you think of Denovicon Therapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.